Canadian Pacific Kansas City Limited Common Shares vs Cronos Group Inc — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $83.86 (market cap $73.71B), while Cronos Group Inc trades at $3.23 (market cap $1.18B). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 62.5× Cronos Group Inc's market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.91% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CP | CRON | |
|---|---|---|
Market Cap | $73.71B | $1.18B |
Volume | 2,143,178 | 968,037 |
Sector | Industrials | Health |
52-Week High | $96.69 | $3.55 |
52-Week Low | $68.88 | $2.30 |
Enterprise Value | $91.14B | $387.62M |
Dividend Yield | 0.91% | — |
Typical Hold Time | — | 22 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Trailing returns across standard periods
Latest headlines on both assets
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →